[1] |
JEMAL A,BRAY F,CENTER M M,et al.Global cancer statistics[J]. CA Cancer J Clin,2011,61(2):69-90.
|
[2] |
赫捷,陈万青. 2012中国肿瘤登记年报[M]. 北京:军事医学科学出版社,2012:10-11.
|
[3] |
GUPTA G P,MASSAGUÉ J.Cancer metastasis:building a framework[J]. Cell,2006,127(4):679-695.
|
[4] |
SUGIURA H,YAMADA K,SUGIURA T,et al.Predictors of survival in patients with bone metastasis of lung cancer[J]. Clin Orthop Relat Res,2008,466(3):729-736.
|
[5] |
TSUKUSHI S,KATAGIRI H,KATAOKA T,et al.Serum tumor markers in skeletal metastasis[J]. Jpn J Clin Oncol,2006,36(7):439-444.
|
[6] |
LIU W,BIAN C,LIANG Y,et al.CX3CL1:a potential chemokine widely involved in the process spinal metastases[J]. Oncotarget,2017,8(9):15213-15219.
|
[7] |
COLEMAN R E.Skeletal complications of malignancy[J]. Cancer,1997,80(8 Suppl):1588-1594.
|
[8] |
SIEGEL R,DESANTIS C,VIRGO K,et al.Cancer treatment and survivorship statistics,2012[J]. CA Cancer J Clin,2012,62(4):220-241.
|
[9] |
DABROWSKA M,GRUBEK-JAWORSKA H,DOMAGAA-KULAWIK J,et al.Diagnostic usefulness of selected tumor markers(CA125,CEA,CYFRA 21-1) in bronchoalveolar lavage fluid in patients with non-small cell lung cancer[J]. Pol Arch Med Wewn,2004,111(6):659-665.
|
[10] |
LUSTER A D.Chemokines-chemotactic cytokines that mediate inflammation[J]. N Engl J Med,1998,338(7):436-445.
|
[11] |
CAI X,LUO J,YANG X,et al.In vivo selection for spine-derived highly metastatic lung cancer cells is associated with increased migration,inflammation and decreased adhesion[J]. Oncotarget,2015,6(26):22905-22917.
|